(Q34551018)

English

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Raymond H Mak

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniel Hunt

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

William U Shipley

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jason A Efstathiou

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

William J Tester

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael P Hagan

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Donald S Kaufman

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Niall M Heney

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anthony L Zietman

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

3 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3801-3809

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

7 July 2018

Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

27 October 2018

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

9 December 2018

LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSED

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239302

9 December 2018

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cystectomy for bladder cancer: a contemporary series

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.57.5548

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_3cn3tuydizgbbildq4osrmbxny

1 reference

https://api.fatcat.wiki/v0/release/3cn3tuydizgbbildq4osrmbxny

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34551018&oldid=1982321216"